There are significant advantages to the production of gene-knockout mice directly in mouse strains other than 129. The availability now of ES cells derived from the C57BL16 mouse strain presents workers with a valuable alternative. A major difficulty, however, is the requirement for BALB/c blastocysts as recipients for ES cell injection. Using standard procedures, few BALB/c blastocysts can be obtained. This limitation has now been resolved by harvesting BALB/c embryos at the early morula stage and maturing these to blastocysts by in vitro culture. Of early morulae harvested and cultured, over 70% were recovered as fully expanded and injectable blastocysts. C57BL/6 ES cell injection of these blastocysts has enabled the production of a number of gene-knockout mice with a success rate similar to that reported for ES cells derived from the 129 mouse strains.
The generation of genetically modified mouse strains by means of homologous recombination in emblyonic stem (ES) cells is now a major research tool in fields as diverse as neurobiology, developmental biology and immunology. It is becoming increasingly obvious that a pure genetic background is highly desirable for the evaluation of effects of gene targeting with insufficient backcrossing producing potentially conflicting results (1, 2) . The genetic control of regulatory and compensatory processes is still insufficiently understood and the genes that control them relatively undefined. Thus, concerns have been raised about the ambiguity of results derived from backcrossed animals and also the exclusive use of the 129 mouse strains in biomedical research (3) .
Efforts to generate stable ES cell lines from mouse strains other than 129 have led to the isolation of C57BL/6 and BALB/c ES cells (2, 4, 5) . To successfully generate chimeric mice with C57BL/6 ES cells, BALB/c-strain blastocysts are the preferrecl recipient (4). However, one major drawback to the use of this strain of blastocyst donor is their delayed embryonic development. We fmd that at d3.5 of gestation, only a fraction (10-20%) of BALB/c embryos are at a fully expanded blastocyst stage and therefore suitable for ES cell injection. A further problem encountered at this stage of gestation is the low yield of embryos per mouse obtainecl from naturally mated animals. We propose altemative methodology that avoids these problems and results in high yields of healthy BALB/c blastocysts that enable good levels of gennline transmission.
Embryos were harvested from BALB/c mice early (7-8 am) on the third day (d3) after natural mating (d0). The timing was critical as later on d3, the yield of healthy embryos was substantially reduced. The uterus was removed and the two uterine homs were flushed as described (6,7). Because of the early stage of the pregnancy we also examined the lower oviduct routinely. Flushing of the uterus and embryo collection was performed with embryo-tested M2 medium (Sigma, St Louis, USA). Recovered embryos exhibited stages of development varying between early and compacted morulae with a few (-2%) being early blastocysts (Table 1 ). All embryos were transferred to M16 medium at 37°C (Sigma, St Louis, USA) then incubated at 37°C in a 5% CO2 atmosphere under embryo-tested mineral oil (Sigma, St Louis, USA). Within 24 h, 70-80% of the cultured embryos were found to develop into fully expanded blastocysts.
Transfected and G418-selected ES cells were thawed from stocks 3 days before injection and cultured basically as described (8) on neomycin-resistant foetal fibroblasts (9) in DMEM (high glucose and sodium pyruvate; Gibco BRL, UK) supplemented with 10% FCS [pre-tested for ES cell culture as described (10)1, 2 mM glutamine (Gibco BRL, UK), 0.1 mM NEAA's (Gibco BRL, UK), 0.1 mM13-mercaptoethanol (Sigma, St Louis, USA) and 200 U/ml L1F (ESGRO, Amrad, Australia). The ES cells were passaged on the day before injection. On the day of injection, ES cells were harvestecl and plated twice on gelatine-coated (0.1%) Petri dishes to remove fibroblasts and resuspended in DMEM, 5% FCS, 50 U/ml DNase (Sigma, St Louis, USA). Twenty four hour-cultured BALB/c blastocysts were micro-injected with ES cells at room temperature. Each blastocyst received between 8-12 ES cells. Injected blastocysts were reimplanted into pseudopregnant (d2.5) foster mothers. Eight blastocysts were implanted in one uterine hom and usually both uterine homs received blastocysts.
The generation of gene knockout mice in the C57BL/6 mouse strain using two separately-derived C57BL/6 ES cell lines and six different cell clones from four transfections are shown ( Table 2 ). All injected ES cell clones resulted in the birth of chimeric mice with the expected bias to the male sex. Each chimeric mouse, irrespective of the level of chimerism, was mated, and two fitters were analysed. With the exception of done #2, all ES cell clones transmitted through the germline. The outcomes here in terms of rates of germline-transmitting chimeras per implanted blastocyst were not significantly different to that reported for 129 ES cells (11) . Two-three female BALB/c mice were naturally mated with one stud male. All females showing vaginal mucus plugs on early moming examination (d0) were sacrificed at d3 of gestation. The light-cycle of the holding room was 0600-1800. aEmbryos collected over seven injection days. hAfter 24 h in vitro culture. eFully expanded and injectable blastocysts. dThe remaining 28% of cells was composed of compacted morulae, incompletely-expanded blastocysts and some non-viable embryos. eMean embryo/blastocyst recovery. The average figure is reduced by inclusion in this data of the 15-20% of plugged mice that remained unfertilised and thus produced no viable embryos. Of those mice plugged and fertilised, 6-8 embryos per mouse were recovered routinely. aInjected blastocysts were often supplemented for reimplantation with uninjected blastocysts to improvelitter size. Thus, figures showh include ES cell-injected plus uninjected blastocysts reimplanted and total pups bom from these reimplantations. Overall, uninjected blastocysts represented -15% of total reimplanted blastocysts. hAll levels of chimerism are included. eAfter two litters. dPercent of total implanted blastocysts. eNumber of chimeric mice or germline-transmitting mice as a percent of total implanted blastocysts. Thus, these figures are probably slight underestimates as a proportion of the implanted blastocysts were not injected with ES cells and could never have generated chimeras. fReference 4. gReference 5. hOne or more of the chimeras were 100% transmitters where all progeny, on crossing with C57BL/6 mice, were black.
Blastocyst injection of ES cell lines is, despite the availability of altemative co-culture techniques (7, 11) , still the method of choice for generation of mouse strains carrying genes targeted by homologous recombination. As genetically and functionally relevant backcrossing (from 129 mice to, for example, C57BL/6) is only practical under specific circumstances where close linkage of other important and modifying genes to the targeted gene can be determined or avoided, the necessity for ES cells from strains other than 129 is increasingly evident. Furthermore, the time advantage in using the strain of choice for direct gene targeting is obvious. The technical modifications outlined here now make BALB/c blastocysts more easily accessible and injection of C57BL/6 ES cells less tedious and laborious.
